Pancreatic Cancer Research

ResearcherCedars-Sinai Medical CenterActive in the last 2 years

Srinivas Gaddam

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6818-6305; OpenAlex author ID A5072357635. Sources: ClinicalTrials.gov.

Their work

Papers
25 (first author 3, last author 5)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
1
Collaborators
90
Papers, trials and grants by year

2020: 1 paper, 1 trial · 2021: 2 papers · 2022: 8 papers · 2023: 3 papers · 2024: 4 papers · 2025: 6 papers · 2026: 1 paper

Papers 25

  1. Young Women With Pancreatic Cancer: A High-Risk Group for Demoralization. Co-author DOI 10.1002/pon.70601↗
  2. Pancreatic Cancer: Screening and Early Detection. Last author DOI 10.1016/j.gtc.2024.09.006↗
  3. Enhancing management of pancreatic cancer: impact of a same day multidisciplinary clinic on access to guideline-directed care. Co-author DOI 10.1016/j.hpb.2025.07.012↗
  4. Circulating tumor cell and oncosome subtypes in portal and peripheral venous circulations may be used for diagnosis and prognostication of pancreatic cancer. Co-author DOI 10.1038/s41698-025-01165-4↗
  5. Evaluating the Effect of KRAS Variants on Survival Outcomes and Therapy Response in Pancreatic Cancer. Co-author DOI 10.1200/po-24-00684↗
  6. Significantly higher incidence of circulating fatty objects in portal blood samples compared to peripheral blood samples in patients with pancreatic ductal ade… Co-author DOI 10.3389/fonc.2025.1611872↗
  7. Predicting Pancreatic Ductal Adenocarcinoma Occurrence Up to 10 Years in Advance Using Features of the Main Pancreatic Duct in Pre-Diagnostic CT Scans. Co-author DOI 10.3390/cancers17111886↗
  8. Accuracy of Clinical Staging in Early-Stage Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1001/jama.2024.16332↗
  9. Cancer-related cells and oncosomes in the liquid biopsy of pancreatic cancer patients undergoing surgery. Co-author DOI 10.1038/s41698-024-00521-0↗
  10. An insight to PDAC tumor heterogeneity across pancreatic subregions using computed tomography images. Co-author DOI 10.3389/fonc.2024.1378691↗
  11. The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocrine Tumors: A Nationwide Time-Trend Analy… Last author DOI 10.3390/cancers16050971↗
  12. Increasing Pancreatic Cancer Incidence in Young Women in the United States: A Population-Based Time-Trend Analysis, 2001-2018. Last author DOI 10.1053/j.gastro.2023.01.022↗
  13. Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance. Co-author DOI 10.1158/1940-6207.capr-22-0529↗
  14. Pancreatic Cancer Incidence Trends by Race, Ethnicity, Age and Sex in the United States: A Population-Based Study, 2000-2018. Last author DOI 10.3390/cancers15030870↗
  15. Incidence of Pancreatic Cancer by Age and Sex in the US From 2000 to 2018-Reply. Co-author DOI 10.1001/jama.2022.2315↗
  16. Standardization of EUS imaging and reporting in high-risk individuals of pancreatic adenocarcinoma: consensus statement of the Pancreatic Cancer Early Detectio… Co-author DOI 10.1016/j.gie.2021.10.025↗
  17. Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-022-19401-3↗
  18. Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-022-23619-6↗
  19. Chemical Exchange Saturation Transfer for Pancreatic Ductal Adenocarcinoma Evaluation. Co-author DOI 10.1097/mpa.0000000000002059↗
  20. Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography images. First author DOI 10.3233/cbm-210273↗
  21. Multitasking dynamic contrast enhanced magnetic resonance imaging can accurately differentiate chronic pancreatitis from pancreatic ductal adenocarcinoma. First author DOI 10.3389/fonc.2022.1007134↗
  22. Risk prediction of pancreatic cancer using AI analysis of pancreatic subregions in computed tomography images. Co-author DOI 10.3389/fonc.2022.1007990↗
  23. Incidence of Pancreatic Cancer by Age and Sex in the US, 2000-2018. Co-author DOI 10.1001/jama.2021.18859↗
  24. Recommendations for a More Organized and Effective Approach to the Early Detection of Pancreatic Cancer From the PRECEDE (Pancreatic Cancer Early Detection) Co… Co-author DOI 10.1053/j.gastro.2021.08.036↗
  25. Six-dimensional quantitative DCE MR Multitasking of the entire abdomen: Method and application to pancreatic ductal adenocarcinoma. First author DOI 10.1002/mrm.28167↗

Trials 1

  1. Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions Principal investigator NCT04324294↗

Closest collaborators

The 25 strongest of 90 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Simon K. Lo · 16 shared papers, 2020–2026 · strength 2.92
  2. Stephen Jacob Pandol · 13 shared papers, 2020–2025 · strength 2.21
  3. Andrew Eugene Hendifar · 12 shared papers, 2020–2026 · strength 1.99
  4. Arsen Osipov · 10 shared papers, 2022–2026 · strength 1.86
  5. Debiao Li · 9 shared papers, 2020–2025 · strength 1.40
  6. Jun Gong · 7 shared papers, 2022–2026 · strength 1.29
  7. Nicholas N. Nissen · 7 shared papers, 2021–2025 · strength 1.23
  8. Lixia Wang · 6 shared papers, 2020–2025 · strength 0.93
  9. Rabindra R. Watson · 4 shared papers, 2023–2025 · strength 0.75
  10. Brent K. Larson · 4 shared papers, 2023–2025 · strength 0.75
  11. Touseef Ahmad Qureshi · 4 shared papers, 2022–2025 · strength 0.70
  12. Yazan Abboud · 4 shared papers, 2021–2024 · strength 0.62
  13. Ghada Mohamed · 2 shared papers, 2024–2025 · strength 0.61
  14. Sehrish Javed · 3 shared papers, 2022–2025 · strength 0.56
  15. Matthew Ebia · 2 shared papers, 2025 · strength 0.44
  16. Abrahm Levi · 2 shared papers, 2025–2026 · strength 0.44
  17. Jamil S. Samaan · 3 shared papers, 2021–2023 · strength 0.43
  18. Stephanie N. Shishido · 2 shared papers, 2024–2025 · strength 0.43
  19. Peter Kühn · 2 shared papers, 2024–2025 · strength 0.43
  20. Cristina Rosa Ferrone · 2 shared papers, 2024–2025 · strength 0.43
  21. Zhaoyang Fan · 3 shared papers, 2020–2022 · strength 0.37
  22. Nan Wang · 3 shared papers, 2020–2022 · strength 0.37
  23. Anthony G Christodoulou · 3 shared papers, 2020–2022 · strength 0.37
  24. Christie Y. Jeon · 2 shared papers, 2022–2025 · strength 0.32
  25. Wansu Chen · 2 shared papers, 2022 · strength 0.28

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.